Position in ZTS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$19,905
-$7,756 QoQ
Shares Held
277
+18.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,190
of 1,408 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Cassaday & Co Wealth Management LLC holds $146,277 across 16 Drug Manufacturers - Specialty & Generic names. ZTS ranks #3 (13.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
254 | $42,809 | |
| 2 | VTRS |
Viatris Inc
|
2,554 | $40,557 | |
| 3 | ZTS |
Zoetis Inc.
This page
|
277 | $19,905 | |
| 4 | BHC |
Bausch Health Companies Inc.
|
2,000 | $9,860 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
275 | $9,317 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
300 | $7,383 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
152 | $5,269 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
39 | $4,326 |
All Filings in ZTS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,905 | 277 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $27,661 | 234 | Shares | Sole | 2026-05-07 | |
| No filing history on record for this holder in this stock. | ||||||